Some of these (FYN, DYRK1A, NOD2, CTSB, SV2C, and ITPKB) may serve as potential PD drug targets due to their involvement in pathways linked to neuroinflammation, autophagy, and neuronal degeneration. This evidence concerns the gene NOD2 and Parkinson disease.